Thromboprophylaxis in hospitalized and nonhospitalized medical patients: what’s new?-Reference-Cited by-同舟云学术

Thromboprophylaxis in hospitalized and nonhospitalized medical patients: what’s new?

Published:2023-09-13 Issue:18 Volume:7 Page:5199-5201
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Rezende Suely M.¹^ORCID,Bauer Kenneth A.²,Zakai Neil A.³⁴^ORCID

Affiliation:

1. 1Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

2. 2Division of Hematology and Hematologic Malignancies, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

3. 3Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT

4. 4Department of Pathology & Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/7/18/5199/2079969/blooda_adv-2023-010067-c-main.pdf

Reference15 articles.

1. American Society of Hematology . . Accessed 4 May 2023. https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines.

2. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients;Schünemann;Blood Adv,2018

3. Adjunctive intermittent pneumatic compression for venous thromboprophylaxis;Arabi;N Engl J Med,2019

4. Rivaroxaban for thromboprophylaxis after hospitalization for medical illness;Spyropoulos;N Engl J Med,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE prophylaxis;Blood Advances;2024-06-14

2. Venous thromboembolism risk models in hospitalized medical patients: the time for implementation, not never-ending development;Research and Practice in Thrombosis and Haemostasis;2024-05

3. Validation of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) risk scores for venous thromboembolism and bleeding in an independent population;Research and Practice in Thrombosis and Haemostasis;2024-05

4. Authors’ response to “Venous Thromboembolism Risk Models in Hospitalized Medical Patients: The Time for Implementation, Not Never-Ending Development”;Research and Practice in Thrombosis and Haemostasis;2024-05